{
  "title": "Behind The Idea #51: DaVita's Murky Economics",
  "description": "DaVita Inc has achieved a rare dual feat - be a staple in Berkshire Hathaway's portfolio and be a target of John Oliver's criticisms. The kidney dialysis provider exemplifies the murky ecosystem of healthcare providers and payments. Does that make it a short? We break down a recent article by Ethan Watkins to see if we can better understand this situation.",
  "pubDate": "Tue, 15 Jan 2019 09:00:00 -0000",
  "itunes:title": "DaVita's Murky Economics",
  "itunes:episodeType": "full",
  "itunes:episode": 51,
  "itunes:author": "Seeking Alpha",
  "itunes:image": "",
  "itunes:subtitle": "Pulling apart the supply and demand of healthcare services is a sticky business.",
  "itunes:summary": "DaVita Inc has achieved a rare dual feat - be a staple in Berkshire Hathaway's portfolio and be a target of John Oliver's criticisms. The kidney dialysis provider exemplifies the murky ecosystem of healthcare providers and payments. Does that make it a short? We break down a recent article by Ethan Watkins to see if we can better understand this situation.",
  "content:encoded": "<p>DaVita Inc has achieved a rare dual feat - be a staple in Berkshire Hathaway's portfolio and be a target of John Oliver's criticisms. The kidney dialysis provider exemplifies the murky ecosystem of healthcare providers and payments. Does that make it a short? We break down a recent article by Ethan Watkins to see if we can better understand this situation.</p>",
  "itunes:duration": 3044,
  "itunes:explicit": "no",
  "guid": "851220f7262c45d6b5b9bd1cc3538523",
  "enclosure": ""
}